NL6617500A - - Google Patents

Info

Publication number
NL6617500A
NL6617500A NL6617500A NL6617500A NL6617500A NL 6617500 A NL6617500 A NL 6617500A NL 6617500 A NL6617500 A NL 6617500A NL 6617500 A NL6617500 A NL 6617500A NL 6617500 A NL6617500 A NL 6617500A
Authority
NL
Netherlands
Application number
NL6617500A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6617500A publication Critical patent/NL6617500A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F23—COMBUSTION APPARATUS; COMBUSTION PROCESSES
    • F23K—FEEDING FUEL TO COMBUSTION APPARATUS
    • F23K3/00—Feeding or distributing of lump or pulverulent fuel to combustion apparatus
    • F23K3/10—Under-feed arrangements
    • F23K3/14—Under-feed arrangements feeding by screw

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Combustion & Propulsion (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL6617500A 1965-12-13 1966-12-13 NL6617500A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51359965A 1965-12-13 1965-12-13
US513553A US3412193A (en) 1965-12-13 1965-12-13 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility

Publications (1)

Publication Number Publication Date
NL6617500A true NL6617500A (fr) 1967-06-14

Family

ID=27057915

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6617500A NL6617500A (fr) 1965-12-13 1966-12-13

Country Status (7)

Country Link
US (1) US3412193A (fr)
BE (1) BE691049A (fr)
CH (1) CH476001A (fr)
DE (1) DE1620057C3 (fr)
FR (1) FR1504326A (fr)
GB (1) GB1129393A (fr)
NL (1) NL6617500A (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) * 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
GB1192812A (en) * 1966-05-20 1970-05-20 American Cyanamid Co 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
US3597429A (en) * 1968-02-15 1971-08-03 Miles Lab Derivatives of tetrazolyl alkanoic acids
GB1265866A (fr) * 1968-08-23 1972-03-08
US3884922A (en) * 1969-07-31 1975-05-20 Yoshitomi Pharmaceutical 11-(4-Pyridylalkyl-piperazino)-dibenzothiazepines
US4049809A (en) * 1976-11-24 1977-09-20 American Cyanamid Company Solution of a oxazepine for oral or parenteral administration
GB1587128A (en) * 1977-04-07 1981-04-01 Hexachimie Benzothiazepine derivatives
US5059600A (en) * 1989-03-31 1991-10-22 Yale University Treating habit disorders
US5223497A (en) * 1989-03-31 1993-06-29 Yale University Treating habit disorders
US5114942A (en) * 1989-03-31 1992-05-19 Yale University Treating habit disorders
WO1999030709A1 (fr) * 1997-12-17 1999-06-24 Merck & Co., Inc. Antagonistes du recepteur de l'integrine
US6890919B2 (en) * 2001-06-26 2005-05-10 Shitij Kapur Atypical antipsychotic agents having low affinity for the D2 receptor
US7388954B2 (en) * 2002-06-24 2008-06-17 Freescale Semiconductor, Inc. Method and apparatus for tone indication
AU2003290079A1 (en) * 2002-12-20 2004-07-14 Basf Aktiengesellschaft Pesticidal dibenzo(hetero)azepine derivatives
US20050250767A1 (en) * 2003-01-23 2005-11-10 Weiner David M Use of N-desmethylclozapine to treat human neuropsychiatric disease
KR20050092123A (ko) * 2003-01-23 2005-09-20 아카디아 파마슈티칼스 인코포레이티드 Ｎ-데스메틸클로자핀의 인간의 신경정신성 질환의 치료용도
EP1658285B1 (fr) 2003-08-20 2007-05-02 Eli Lilly And Company Composes, procedes et preparations destines a l'apport oral d'un compose peptidique de type glucagon (glp-1) ou d'un peptide agoniste du recepteur 4 de melanocortine (mc4)
DE602004004156T2 (de) 2003-08-20 2007-10-11 Eli Lilly And Co., Indianapolis Verbindungen, verfahren und formulierungen zur oralen verabreichung einer glucagon like peptide (glp)-1-verbindung oder eines am melanocortin-4-rezeptor (mc4) als agonist wirkenden peptids
EP1696931B1 (fr) * 2003-12-22 2009-03-25 Acadia Pharmaceuticals Inc. Analogues de diaryl[a,d]cycloheptene amino substitues utilises comme agonistes muscariniques, et procedes de traitement de troubles neuropsychiatriques
BRPI0509524A (pt) * 2004-04-01 2007-09-18 Acadia Pharm Inc formas cristalinas de n-desmetilclozapina
US20070105836A1 (en) * 2005-10-31 2007-05-10 Lars Pettersson Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
WO2009154563A1 (fr) * 2008-06-20 2009-12-23 Astrazeneca Ab Dérivés de dibenzothiazépine et leur utilisation

Also Published As

Publication number Publication date
GB1129393A (en) 1968-10-02
US3412193A (en) 1968-11-19
BE691049A (fr) 1967-05-16
DE1620057A1 (de) 1970-03-19
DE1620057B2 (de) 1977-10-06
FR1504326A (fr) 1967-12-01
CH476001A (de) 1969-07-31
DE1620057C3 (de) 1978-06-08

Similar Documents

Publication Publication Date Title
BE675012A (fr)
BE675068A (fr)
BE661447A (fr)
BE662160A (fr)
BE662276A (fr)
BE664138A (fr)
BE664338A (fr)
BE665744A (fr)
BE667963A (fr)
BE668061A (fr)
BE668312A (fr)
BE669021A (fr)
BE669258A (fr)
BE669488A (fr)
BE669938A (fr)
BE670383A (fr)
BE670814A (fr)
BE671031A (fr)
BE671091A (fr)
BE671106A (fr)
BE675014A (fr)
BE671947A (fr)
BE672057A (fr)
BE672082A (fr)
BE672914A (fr)